Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2015 09:17 ET | Source: Hadasit Bio-Holdings Ltd.

Enlivex Granted EU Orphan Drug Designation for Lead Product ApoCell for Graft-Versus-Host Disease

JERUSALEM, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Enlivex Therapeutics (Enlivex), a Hadasit Bio-Holdings ("HBL") (TASE:HDST) (OTCQB:HADSY) portfolio company, today announced that the European Medicines...